[go: up one dir, main page]

WO2012090043A8 - Novel solid state forms of azilsartan medoxomil and preparation thereof - Google Patents

Novel solid state forms of azilsartan medoxomil and preparation thereof Download PDF

Info

Publication number
WO2012090043A8
WO2012090043A8 PCT/IB2011/003055 IB2011003055W WO2012090043A8 WO 2012090043 A8 WO2012090043 A8 WO 2012090043A8 IB 2011003055 W IB2011003055 W IB 2011003055W WO 2012090043 A8 WO2012090043 A8 WO 2012090043A8
Authority
WO
WIPO (PCT)
Prior art keywords
solid state
preparation
azilsartan medoxomil
state forms
novel solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2011/003055
Other languages
French (fr)
Other versions
WO2012090043A1 (en
Inventor
Himanchal MISHRA
Deepak Bansal
Muni Bhaskar PALLOORU
Alka Srivastava CHOUDHARY
Dharam Vir
Ashutosh Agarwal
Shailendr Kumar DUBEY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jubilant Pharmova Ltd
Original Assignee
Jubilant Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jubilant Life Sciences Ltd filed Critical Jubilant Life Sciences Ltd
Publication of WO2012090043A1 publication Critical patent/WO2012090043A1/en
Publication of WO2012090043A8 publication Critical patent/WO2012090043A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The present invention provides novel solid state forms of azilsartan medoxomil and process for the preparation thereof. The solid state forms of the present invention includes crystalline forms viz. J2, J3, J4, J5, J6, J7, J8, J9 and amorphous forms of azilsartan medoxomil. Further, it relates to the pharmaceutical composition and use of the said formulation to treat the conditions in a subject in need thereof.
PCT/IB2011/003055 2010-12-29 2011-12-16 Novel solid state forms of azilsartan medoxomil and preparation thereof Ceased WO2012090043A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN3155DE2010 2010-12-29
IN3155/DEL/2010 2010-12-29
IN316DE2011 2011-02-08
IN316/DEL/2011 2011-02-08

Publications (2)

Publication Number Publication Date
WO2012090043A1 WO2012090043A1 (en) 2012-07-05
WO2012090043A8 true WO2012090043A8 (en) 2012-09-13

Family

ID=45540893

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2011/003055 Ceased WO2012090043A1 (en) 2010-12-29 2011-12-16 Novel solid state forms of azilsartan medoxomil and preparation thereof

Country Status (1)

Country Link
WO (1) WO2012090043A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102323280A (en) * 2011-05-11 2012-01-18 浙江长生鸟珍珠生物科技有限公司 Quality detection methods of pearl powder and application thereof
WO2013042066A1 (en) * 2011-09-20 2013-03-28 Ranbaxy Laboratories Limited Process for the preparation of azilsartan medoxomil
WO2013104342A1 (en) * 2012-01-14 2013-07-18 Sunshine Lake Pharma Co., Ltd. Crystalline forms of azilsartan medoxomil potassium and preparation and uses thereof
WO2013124748A1 (en) * 2012-02-20 2013-08-29 Alembic Pharmaceuticals Limited Novel polymorphs of azilsartan medoxomil potassium
CZ2012274A3 (en) * 2012-04-19 2013-10-30 Zentiva, K.S. Process for preparing extremely pure potassium salt of azilsartan medoxomil
WO2013186792A2 (en) * 2012-06-11 2013-12-19 Msn Laboratories Limited Process for the preparation of (5-methyl-2-oxo-l,3-dioxoi-4-vl)methvl 2- ethoxv-l-{[2'-(5-oxo-4,5-dihvdro-l,2,4-oxadiazol-3-vl)biphenyi-4-vl]methyl}- lh-benzimidazole-7-carboxyiate and its salts
US20150291574A1 (en) * 2012-07-09 2015-10-15 Bandi Parthasaradhi Reddy Novel polymorphs of azilsartan
WO2014020381A1 (en) * 2012-08-01 2014-02-06 Alembic Pharmaceuticals Limited Novel crystalline form of azilsartan medoxomil potassium
US9314753B2 (en) * 2012-08-27 2016-04-19 Stempeutics Research Private Limited Multi plane mixer and separator (MPMS) system
WO2014049512A2 (en) 2012-09-26 2014-04-03 Lupin Limited Novel process for preparation of azilsartan medoxomil
CZ305318B6 (en) * 2012-09-26 2015-07-29 Zentiva, K.S. Process for preparing extremely pure azilsartan medoxomil potassium salt
CN103709154B (en) * 2012-09-28 2016-06-15 武汉朗来科技发展有限公司 Benzimidazole derivative and its preparation method and medical application
CN103880829B (en) * 2012-12-21 2016-07-06 上海医药工业研究院 A kind of Azilsartan crystal and its production and use
CN103910720A (en) * 2013-01-07 2014-07-09 广东东阳光药业有限公司 Novel crystal form of azilsartan medoxomil and preparation method thereof
CN105153141B (en) * 2013-02-04 2018-09-25 武汉朗来科技发展有限公司 Benzimidizole derivatives and preparation method thereof and medical usage
CN104774196B (en) * 2014-01-09 2017-11-10 武汉朗来科技发展有限公司 A kind of preparation method of benzimidizole derivatives
CN104557899B (en) * 2014-11-17 2018-05-22 江苏中邦制药有限公司 A kind of preparation method of Azilsartan I crystal crystal
WO2016145622A1 (en) 2015-03-18 2016-09-22 武汉朗来科技发展有限公司 Benzimidazole derivatives, preparation method therefor and medicinal use thereof
CN106032378B (en) * 2015-03-20 2019-10-25 武汉启瑞药业有限公司 New A RB compound and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157584B2 (en) * 2004-02-25 2007-01-02 Takeda Pharmaceutical Company Limited Benzimidazole derivative and use thereof

Also Published As

Publication number Publication date
WO2012090043A1 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
WO2012090043A8 (en) Novel solid state forms of azilsartan medoxomil and preparation thereof
WO2012068441A3 (en) Intedanib salts and solid state forms thereof
WO2011150156A3 (en) Heteroaryl compounds and methods of use thereof
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
WO2011121418A9 (en) 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists
WO2010132882A3 (en) Sublingual dexmedetomidine compositions and methods of use thereof
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
WO2011057262A3 (en) Treatment of infections with tp receptor antagonists
WO2010049454A3 (en) Antimicrobial composition from copepods
WO2010092090A3 (en) Novel salts of sitagliptin
WO2009019303A3 (en) A process for the preparation or purification of olmesartan medoxomil
WO2012085927A3 (en) Tadalafil compositions
WO2010005565A3 (en) Method of treating glycogen storage disease
WO2010008735A3 (en) Solid states of o-desmethylvenlaf axine salts
WO2008137134A3 (en) Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
WO2011080254A3 (en) Fungicide hydroximoyl-heterocycles derivatives
WO2010129636A3 (en) Lenalidomide polymorph
WO2012063269A3 (en) Process for preparing iloperidone
SI2081904T1 (en) Aripiprazole hemifumarate and process for its preparation
WO2010079045A3 (en) Crystalline salt forms of flibanserine
WO2012148148A3 (en) Novel zinc azide complex and a process for preparing tetrazole derivatives using the same
WO2012019428A8 (en) Benzohydrol derivatives, a preparation process and pharmaceutical use thereof
WO2013088384A3 (en) Solid state forms of azilsartan and azilsartan medoxomil monopotassium and preparation thereof
WO2012029074A3 (en) Pharmaceutical compositions of linezolid
WO2010061220A3 (en) Novel processes and pure polymorphs

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11813689

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11813689

Country of ref document: EP

Kind code of ref document: A1